Cargando…
WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
We report a 50-year-old woman with no relevant clinical history who presented with headache and loss of memory. Magnetic resonance imaging showed a left parieto-temporal mass with annular enhancement after contrast media administration, rendering a radiological diagnosis of high-grade astrocytic neo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508570/ https://www.ncbi.nlm.nih.gov/pubmed/26081826 http://dx.doi.org/10.4132/jptm.2015.05.20 |
_version_ | 1782381949632905216 |
---|---|
author | Escalante Abril, Paola A. Salazar, Miguel Fdo. López García, Nubia L. Madrazo Moya, Mónica N. Zamora Guerra, Yadir U. Mata Mendoza, Yadira Gandhi Gómez Apo, Erick Chávez Macías, Laura G. |
author_facet | Escalante Abril, Paola A. Salazar, Miguel Fdo. López García, Nubia L. Madrazo Moya, Mónica N. Zamora Guerra, Yadir U. Mata Mendoza, Yadira Gandhi Gómez Apo, Erick Chávez Macías, Laura G. |
author_sort | Escalante Abril, Paola A. |
collection | PubMed |
description | We report a 50-year-old woman with no relevant clinical history who presented with headache and loss of memory. Magnetic resonance imaging showed a left parieto-temporal mass with annular enhancement after contrast media administration, rendering a radiological diagnosis of high-grade astrocytic neoplasm. Tumour sampling was performed but the patient ultimately died as a result of disease. Microscopically, the lesion had areas of glioblastoma mixed with a benign mesenchymal constituent; the former showed hypercellularity, endothelial proliferation, high mitotic activity and necrosis, while the latter showed fascicles of long spindle cells surrounded by collagen and reticulin fibers. With approximately 40 previously reported cases, gliofibroma is a rare neoplasm defined as either glio-desmoplastic or glial/benign mesenchymal. As shown in our case, its prognosis is apparently determined by the degree of anaplasia of the glial component. |
format | Online Article Text |
id | pubmed-4508570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | The Korean Society of Pathologists and the Korean Society for Cytopathology |
record_format | MEDLINE/PubMed |
spelling | pubmed-45085702015-07-21 WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm Escalante Abril, Paola A. Salazar, Miguel Fdo. López García, Nubia L. Madrazo Moya, Mónica N. Zamora Guerra, Yadir U. Mata Mendoza, Yadira Gandhi Gómez Apo, Erick Chávez Macías, Laura G. J Pathol Transl Med Case Study We report a 50-year-old woman with no relevant clinical history who presented with headache and loss of memory. Magnetic resonance imaging showed a left parieto-temporal mass with annular enhancement after contrast media administration, rendering a radiological diagnosis of high-grade astrocytic neoplasm. Tumour sampling was performed but the patient ultimately died as a result of disease. Microscopically, the lesion had areas of glioblastoma mixed with a benign mesenchymal constituent; the former showed hypercellularity, endothelial proliferation, high mitotic activity and necrosis, while the latter showed fascicles of long spindle cells surrounded by collagen and reticulin fibers. With approximately 40 previously reported cases, gliofibroma is a rare neoplasm defined as either glio-desmoplastic or glial/benign mesenchymal. As shown in our case, its prognosis is apparently determined by the degree of anaplasia of the glial component. The Korean Society of Pathologists and the Korean Society for Cytopathology 2015-07 2015-06-17 /pmc/articles/PMC4508570/ /pubmed/26081826 http://dx.doi.org/10.4132/jptm.2015.05.20 Text en © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Study Escalante Abril, Paola A. Salazar, Miguel Fdo. López García, Nubia L. Madrazo Moya, Mónica N. Zamora Guerra, Yadir U. Mata Mendoza, Yadira Gandhi Gómez Apo, Erick Chávez Macías, Laura G. WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm |
title | WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm |
title_full | WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm |
title_fullStr | WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm |
title_full_unstemmed | WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm |
title_short | WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm |
title_sort | who grade iv gliofibroma: a grading label denoting malignancy for an otherwise commonly misinterpreted neoplasm |
topic | Case Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508570/ https://www.ncbi.nlm.nih.gov/pubmed/26081826 http://dx.doi.org/10.4132/jptm.2015.05.20 |
work_keys_str_mv | AT escalanteabrilpaolaa whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm AT salazarmiguelfdo whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm AT lopezgarcianubial whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm AT madrazomoyamonican whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm AT zamoraguerrayadiru whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm AT matamendozayadiragandhi whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm AT gomezapoerick whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm AT chavezmaciaslaurag whogradeivgliofibromaagradinglabeldenotingmalignancyforanotherwisecommonlymisinterpretedneoplasm |